These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 21255462)
1. Finding a cure for HIV: will it ever be achievable? Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462 [TBL] [Abstract][Full Text] [Related]
2. HIV cure and eradication: how will we get from the laboratory to effective clinical trials? Lewin SR; Rouzioux C AIDS; 2011 Apr; 25(7):885-97. PubMed ID: 21422987 [TBL] [Abstract][Full Text] [Related]
3. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Pierson T; McArthur J; Siliciano RF Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072 [TBL] [Abstract][Full Text] [Related]
4. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication. Shan L; Siliciano RF Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347 [TBL] [Abstract][Full Text] [Related]
5. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy. Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056 [TBL] [Abstract][Full Text] [Related]
6. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S J Virol; 2018 May; 92(9):. PubMed ID: 29444937 [TBL] [Abstract][Full Text] [Related]
7. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407 [TBL] [Abstract][Full Text] [Related]
8. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents. Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644 [TBL] [Abstract][Full Text] [Related]
9. HDAC inhibitors in HIV. Wightman F; Ellenberg P; Churchill M; Lewin SR Immunol Cell Biol; 2012 Jan; 90(1):47-54. PubMed ID: 22083528 [TBL] [Abstract][Full Text] [Related]
10. HIV Persistence, Latency, and Cure Approaches: Where Are We Now? Chou TC; Maggirwar NS; Marsden MD Viruses; 2024 Jul; 16(7):. PubMed ID: 39066325 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells. Sluis-Cremer N Curr Top Med Chem; 2016; 16(10):1191-7. PubMed ID: 26324046 [TBL] [Abstract][Full Text] [Related]
12. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay. Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716 [TBL] [Abstract][Full Text] [Related]
13. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat. Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643 [TBL] [Abstract][Full Text] [Related]
14. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583 [TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4 Yim LY; Lam KS; Luk TY; Mo Y; Lu X; Wang J; Cheung KW; Lui GCY; Chan DPC; Wong BCK; Lau TT; Ngan CB; Zhou D; Wong YC; Tan Z; Liu L; Wu H; Zhang T; Lee SS; Chen Z J Virol; 2023 May; 97(5):e0027023. PubMed ID: 37042759 [TBL] [Abstract][Full Text] [Related]
16. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators. Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors. Banga R; Procopio FA; Cavassini M; Perreau M J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693 [TBL] [Abstract][Full Text] [Related]
18. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV. Rochat MA; Schlaepfer E; Speck RF J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016 [TBL] [Abstract][Full Text] [Related]